Inhibition of angiogenesis or preventing the outgrowth of new blood vessels towards a tumor
is one of the most promising areas of anticancer drug development. Several angiogenesis …

Angiogenesis, or new blood vessel formation, is now known to play an important role in both
growth and metastasis of many cancers. The central importance of angiogenesis and the …

Tumor blood vessels are a key target for cancer therapeutic management. Tumor cells
secrete high levels of pro-angiogenic factors which contribute to the creation of an abnormal …

A significant body of research has implicated the process of angiogenesis in the growth and
spread of tumors. Elucidation of the mechanisms of tumor angiogenesis has led to the …

The great interest in the potential antineoplastic effect of targeting tumor-associated blood
vessels has generated an expanding armamentarium of therapeutic tools that include …

Angiogenesis plays a crucial role in facilitating tumor growth and the metastatic process, and
it is the result of a dynamic balance between pro-angiogenic factors, like vascular …

Angiogenesis, the growth of new blood vessels, is a fundamental physiological process
required for development, reproduction, and wound repair and as a tissue response to …

Anti-angiogenic therapy in cancer has become very popular. Agents inhibiting new vessel
formation (angiogenesis) and blood supply can have anticancer effects. This idea …

Angiogenesis is a critical step in the progression of tumours from dormancy to a clinical
relevant cancer. Inhibition of this process is one of the most promising new anti‐cancer …

Enhancing chemotherapy delivery to tumors, improving tumor growth control, reducing
metastasis, and increasing survival are all critical objectives of improved cancer therapy …